873PSafety and tolerability of atezolizumab (atezo) plus bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC): Pooled analysis of IMmotion150 and IMmotion151. (23rd October 2018) - Suarez, C; Choueiri, T K; McDermott, D F; Escudier, B; Atkins, M B; Powles, T B; Rini, B I; Motzer, R J; Pal, S K; Fong, L; De Giorgi, U; Wang, Y; et al.